Navigation Links
Neural stem cells maintain high levels of reactive oxygen species, UCLA study finds
Date:1/6/2011

it needs it. Some cells, such as immune cells, surround bacteria or viruses and use ROS to kill the invading microbes. Outside influences such as stress and environmental factors such as exposure to radiation can increase ROS levels in cells.

Although ROS is produced by all cells in a passive manner as a by-product of normal cell metabolism, some cells also produce ROS in a directed manner using ROS-producing enzymes like NADPH oxidase (NOX). NOX-generated ROS can act as second messengers in tightly controlled signal transduction pathways for many growth and trophic factors. However, too much ROS damages and ultimately kills cells, so finding the correct balance is vital, Kornblum said. And in fact, when the neural stem cells in the study were given too much ROS, they did die.

Kornblum and his team also found that the ROS-mediated stem cell self-renewal and differentiation of these cells into neurons depended on a cell signaling pathway called PI3K/Akt, which is known to be involved in cellular functions such as cell growth, proliferation, differentiation, motility and survival. NOX-generated ROS affect PI3K/Akt signaling by causing the inactivation of the PTEN protein, an important tumor suppressor and negative regulator of the pathway, by oxidizing a cysteine residue in the protein, which inactivates its function.

Kornblum and his collaborators at UCLA, including Dr. Hong Wu, a professor of molecular and medical pharmacology and a co-author of the study, have been studying the PI3K pathway for years. The pathway is activated in some diseases, for example a subset of autism cases and in tuberous sclerosis, a rare, multi-system genetic disease that causes non-malignant tumors to grow in the brain and in other vital organs. The pathway also can be activated in certain cancers.

"One of our hypotheses is that in these disease states, for instance in autism, that in those with a genetic predisposition to PI3K activation, exposur
'/>"/>

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Swiss agency approves clinical trial of UCI-created neural stem cell therapy
2. Neuralstem files FDA application for first drug therapy
3. How do neural stem cells decide what to be -- and when?
4. Neuralstem updates ALS clinical trial progress
5. Neuralstem chief scientific officer to take part in World Stem Cell Summit plenary session
6. Neuralstem stem cells survive and differentiate into neurons in rats with stroke
7. Misfolded neural proteins linked to autism disorders
8. The neural basis of the depressive self
9. Hurts so good -- neural clues to the calming effects of self-harm
10. Neuralstem files FDA application for first chronic spinal cord injury stem cell trial
11. Human neural stem cells restore motor function in mice with chronic spinal cord injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Unlike children, the vast majority of adults finish all of ... to a new study. This is true for ... researchers from Cornell University revealed. They noted their findings ... eating habits make better choices. "If you put it ... Wansink, director of the Cornell Food and Brand Lab, ...
(Date:7/25/2014)... genes are switched on or off plays a key ... metabolism, UT Southwestern Medical Center researchers have found., The ... obesity and diabetes, since the transcription factor involved ... influence the body,s sensitivity to insulin and leptin signaling. ... regulation of food intake and sugar disposal, and obesity ...
(Date:7/25/2014)... July 25, 2014 The American Brain ... volunteer network “ABTA CommYOUnity™” during its annual patient and ... time for the brain tumor community as we – ... and caregiver support services and funding brain tumor research ... passionate about brain tumor awareness and getting our materials ...
(Date:7/25/2014)... Progress in understanding the molecular genetics of ... promising brain tumor treatments, according to Patrick Wen, MD, ... Center for Neuro-Oncology, Dana-Farber Cancer Institute. , At the ... Conference in Chicago, July 25-26, Dr. Wen will moderate ... impacting the development of new treatments and advancing strategies ...
(Date:7/25/2014)... San Jose, CA (PRWEB) July 25, 2014 ... MaaS360 WorkPlace Partner Program . Splashtop Business and ... MaaS360 Market, and will leverage the MaaS360 WorkPlace ... corporate data. , Splashtop Business and Splashtop Enterprise offer ... using any device. High performance, ease of ...
Breaking Medicine News(10 mins):Health News:Most Adults Are Members of 'Clean Plate Club' 2Health News:Manipulating key protein in the brain holds potential against obesity and diabetes 2Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 2Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 3Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 2Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 3Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 4Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 2Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 3Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 4
... of Hodgkin lymphoma, a common form of cancer of ... white blood cells (B cells), but have lost a ... The phenotype and the characteristics of Hodgkin lymphoma cells ... (Max Delbrck Center for Molecular Medicine, MDC, Berlin-Buch and ...
... Study finds 1 in 4 terminally ill not getting ... (HealthDay News) -- Oregon,s physician-assisted suicide law may not ... with clinical depression, a new study says. , The ... in 1997, and there,s been intense debate about the ...
... understand whether they may benefit from more,intensive screening, monitoring ... deCODE genetics,(Nasdaq: DCGN ) today announced the ... of the common forms of breast cancer. For the ... with her physician,about a genetic test to better understand ...
... Nominations are now being,accepted for The 2009 ... scientists in basic or clinical research who have ... Nominations will be accepted online at http://www.pauljanssenaward.com ... independent Selection,Committee. The winner(s) will be announced in ...
... TransForce(R)2 Arch Developer ... ... global manufacturer of orthodontic products, laboratory services,and continuing education programs, announced ... their new and improved,TransForce2 Arch Developer Appliances. Two styles of the ...
... 8 The following statement was,issued today by ... bad,decisions that is a major contributing factor to ... of healthcare, reducing access and,dramatically adding to healthcare ... a significant increase according to recent polls.,Access difficulty ...
Cached Medicine News:Health News:Hodgkin lymphoma -- new characteristics discovered 2Health News:Hodgkin lymphoma -- new characteristics discovered 3Health News:Oregon's Assisted Suicide Law May Overlook Depressed Patients 2Health News:deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Breast Cancer 2Health News:deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Breast Cancer 3Health News:deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Breast Cancer 4Health News:deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Breast Cancer 5Health News:deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Breast Cancer 6Health News:deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Breast Cancer 7Health News:2009 Nominations Open for The Dr. Paul Janssen Award for Biomedical Research 2Health News:2009 Nominations Open for The Dr. Paul Janssen Award for Biomedical Research 3Health News:The Next Generation of Arch Expansion has Arrived 2Health News:HealthMadeEasy.com: Our Healthcare System Is Hemorrhaging 2Health News:HealthMadeEasy.com: Our Healthcare System Is Hemorrhaging 3
(Date:7/25/2014)... -- CVS Caremark Corporation (NYSE: CVS ) will ... 2014, at 8:30 a.m. (EDT) with analysts and investors ... An audio webcast of the conference call will ... the CVS Caremark website for all interested parties.  To ... will be archived and available on the web site ...
(Date:7/25/2014)... July 25, 2014  Acsis Inc., the market ... serialization solutions, has recently posted an article, ... current and future needs for companies, extended supply ... supply chain model no longer work today.  The ... the growth of mobile technology, machine to machine ...
(Date:7/25/2014)... Research and Markets has announced ... Market 2014-2018" report to their offering. ... Diagnostic Device An ophthalmic diagnostic device ... or deficiency in the human visual pathway. Ophthalmic devices ... presbyopia, cataracts, glaucoma, retinal disorders, conjunctivitis, and dry eyes. ...
Breaking Medicine Technology:Acsis Addresses Questions on the Modern Supply Chain 2Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2
... 2011 Thoratec Corporation (Nasdaq: THOR ), a ... support and restore failing hearts, today announced that it will ... 2011 on Tuesday, November 1. The company will ... operating activities, open to all interested parties, at 1:30 p.m., ...
... 2011 NxStage Medical, Inc. (Nasdaq: ... products, today announced it ranked 141 on Deloitte,s Technology ... media, telecommunications, life sciences and clean technology companies in ... year revenue growth during the period from 2006–2010. NxStage ...
Cached Medicine Technology:Thoratec Schedules Third Quarter Conference Call, Webcast 2NxStage® Ranked Number 141 on the Fastest Growing Company in North America on Deloitte's 2011 Technology Fast 500™ 2NxStage® Ranked Number 141 on the Fastest Growing Company in North America on Deloitte's 2011 Technology Fast 500™ 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: